OOIR: Observatory of International Research

Papers

(The median citation count of Critical Reviews in Microbiology is 5. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-06-01 to 2025-06-01.)

Article	Citations
Male-specific bacteriophages and their potential on combating the spreading of T4SS-bearing antimicrobial resistance plasmids	145
Neuroinflammation-mediated relationship between oral microbiome and neurodegenerative diseases	75
Dynamics of antibiotic resistance genes in plasmids and bacteriophages	66
TREM-2: friend or foe in infectious diseases?	65
EnterohepaticHelicobacterspecies – clinical importance, host range, and zoonotic potential	56
Salmonella in eggs and egg-laying chickens: pathways to effective control	52
Helicobacter pylori infection: from standard to alternative treatment strategies	42
Host and bacterial lipid metabolism during tuberculosis infections: possibilities to synergise host- and bacteria-directed therapies	40
Paving the way forward: Escherichia coli bacteriophages in a One Health approach	37
Antimicrobial peptides as promising antibiotic adjuvants to combat drug-resistant pathogens	36
Engineered probiotics as live biotherapeutics for diagnosis and treatment of human diseases	36
Targeting bioinformatics tools to study the dissemination and spread of antibiotic resistant genes in the environment and clinical settings	33
The cross-talk between mucormycosis, steroids and diabetes mellitus amidst the global contagion of COVID-19	33
Outer membrane proteins and vesicles as promising vaccine candidates against Vibrio spp. infections	32
Relevance of organ(s)-on-a-chip systems to the investigation of food-gut microbiota-host interactions	32
Biosynthesis, regulation, and biological significance of fumonisins in fungi: current status and prospects	30
Antibiotic heteroresistance: an important factor in the failure of Helicobacter Pylori eradication	29
Exploring halophilic environments as a source of new antibiotics	27
LysR-type transcriptional regulators: state of the art	27
Applications of bacteriophages against intracellular bacteria	27
Vibrio cholerae virulence and its suppression through the quorum-sensing system	26
Bile acid–gut microbiota crosstalk in irritable bowel syndrome	26
Biofilm formation in clinically relevant filamentous fungi: a therapeutic challenge	25
Interplay between Clostridioides difficile infection, host immunity, and metabolism: a comprehensive review	25
The microbiome and precision oncology: an emerging paradigm in anticancer therapy	24

Advances in the applications of Bacteriophages and phage products against food-contaminating bacteria	24
Emerging cellular and molecular interactions between the lung microbiota and lung diseases	24
The role of influenza A virus-induced hypercytokinemia	23
Polyamine as a microenvironment factor in resistance to antibiotics	23
The diffusible signaling factor family in microbial signaling: a current perspective	22
Endophytic fungi-bioinspired nanoparticles potential to control infectious disease	22
The role of single and mixed biofilms in Clostridioides difficile infection and strategies for prevention and inhibition	21
Probiotics for pancreatic β-cell function: from possible mechanism of action to assessment of effectiveness	21
Building up a clinical microbiota profiling: a quality framework proposal	21
Phage-bacterial evolutionary interactions: experimental models and complications	20
Microbial persisters and host: recent advances and future perspectives	19
Emerging strategies to target virulence in Pseudomonas aeruginosa respiratory infections	19
Burkholderia in the genomic era: from taxonomy to the discovery of new antimicrobial secondary metabolites	18
Emergence of persister cells in Staphylococcus aureus : calculated or fortuitous move?	18
Antibiotic resistance in Pseudomonas aeruginosa : mechanisms and emerging treatment	18
Ocular surface microbiota dysbiosis contributes to the high prevalence of dry eye disease in diabetic patients	16
Ureaplasma infections: update on epidemiology, antimicrobial resistance, and pathogenesis	16
Microbial biosynthesis of nucleos(t)ide analogs: applications, and engineering optimization	16
Multidrug-resistantTrichosporonspecies: underestimated fungal pathogens posing imminent threats in clinical settings	16
Quorum sensing in biofilms: a key mechanism to target in ecotoxicological studies	15
Current types of staphylococcal cassette chromosome mec (SCC mec ) in clinically relevant coagulase-negative staphylococcal (CoNS) species	15
Advances in mining and expressing microbial biosynthetic gene clusters	14
Porphyromonas gingivalis and the pathogenesis of Alzheimer’s disease	14
Bacillusspore-forming probiotics: benefits with concerns?	14
Nanophotocatalysts against viruses and antibiotic-resistant bacteria: recent advances	14
The role of the probiotic Akkermansia muciniphila in brain functions: insights underpinning therapeutic potential	13
The potential for bacteriophages and prophage elements in fighting and preventing the gonorrhea	13
Review on computer-assisted biosynthetic capacities elucidation to assess metabolic interactions and communication within microbial communities	13
Community dynamics of subgingival microbiome in periodontitis and targets for microbiome modulation therapy	12
The crosstalk between SUMOylation and immune system in host-pathogen interactions	12
Designing and development of epitope-based vaccines againstHelicobacter pylori	11
Mechanisms underlying the effects, and clinical applications, of oral microbiota in lung cancer: current challenges and prospects	11
Bdellovibrio and like organisms: current understanding and knowledge gaps of the smallest cellular hunters of the microbial world	11
Aspergilli series Versicolores: importance of species identification in the clinical setting	11
Insights into the molecular basis of c-di-GMP signalling in Pseudomonas aeruginosa	11
Unravelling the sponge microbiome as a promising source of biosurfactants	10
Genetic basis of antibiotic resistance in bovine mastitis and its possible implications for human and ecological health	10
Current and novel therapies for management of Acinetobacter baumannii -associated pneumonia	10
Antibiotic resistance genes in Escherichia coli – literature review	10
Roles of alcohol dehydrogenase 1 in the biological activities of Candida albicans	10
Marine microbial enzymes as potential antibiofilm agents: expanding the arsenal of bioactive agents targeting biofilm-forming microorganisms	9
Phage-inspired strategies to combat antibacterial resistance	9
The high osmolarity glycerol (HOG) pathway in fungi^†	9
Natural and synthetic molecules with potential to enhance biofilm formation and virulence properties in Pseudomonas aeruginosa	9
Ex vivo challenge models for infectious diseases	9
Towards the discovery of novel molecular clocks in Prokaryotes	8
The complement system as a key modulator of the oral microbiome in health and disease	8
Multiple potential strategies for the application of nisin and derivatives	8
Are anaerobic fungi crucial hidden players of microbiomes in anoxic environment?	8
Acinetobacter baumannii subunit vaccines: recent progress and challenges	8

Antimicrobial coatings for environmental surfaces in hospitals: a potential new pillar for prevention strategies in hygiene	8
Virovory: control of viral pathogenesis by the protists and the way forward	8
Molecular imaging of bacterial biofilms—a systematic review	8
Peeling off the layers from microbial dark matter (MDM): recent advances, future challenges, and opportunities	8
Microparticles and nanoparticles-based approaches to improve oral treatment of Helicobacter pylori infection	8
Bacterial adhesion to collagens: implications for biofilm formation and disease progression in the oral cavity	8
Interactions between the foreign body reaction andStaphylococcus aureusbiomaterial-associated infection. Winning strategies in the derby on biomaterial implant surfaces	8
Rapid diagnosis and precision treatment of Helicobacter pylori infection in clinical settings	8
Nasal microbiome dynamics: decoding the intricate nexus in the progression of respiratory and neurological diseases	8
Biosensors for the detection ofMycobacterium tuberculosis: a comprehensive overview	7
Peptide-based strategies for overcoming biofilm-associated infections: a comprehensive review	7
Selective pressures for public antibiotic resistance	7
Polymicrobial biofilms related to dental implant diseases: unravelling the critical role of extracellular biofilm matrix	7
A comprehensive review of Bifidobacterium spp : as a probiotic, application in the food and therapeutic, and forthcoming trends	7
The role of membrane contact sites at the bacteria-host interface	7
Macrophage biology in the pathogenesis of Helicobacter pylori infection	7
Recent advances in understanding of multifaceted changes in the vaginal microenvironment: implications in vaginal health and therapeutics	7
Blocking horizontal transfer of antibiotic resistance genes: an effective strategy in combating antibiotic resistance	7
Regulatory transcription factors of Clostridioides difficile pathogenesis with a focus on toxin regulation	7
Activation of host nucleic acid sensors by Mycobacterium : good for us or good for them?	6
Water and mosquitoes as key components of the infective cycle of Francisella tularensis in Europe: a review	6
Evaluation of the antifungal effect of plant extracts on oral Candida spp. – a critical methodological analysis of the last decade	6
The WxxxE proteins in microbial pathogenesis	6
Interplay between gut microbiota and bile acids in diarrhoea-predominant irritable bowel syndrome: a review	6
The search for aliens within us: a review of evidence and theory regarding the foetal microbiome	6
A multifarious bacterial surface display: potential platform for biotechnological applications	6
Anti-fungal peptides: an emerging category with enthralling therapeutic prospects in the treatment of candidiasis	6
The battle within: how Pseudomonas aeruginosa uses host-pathogen interactions to infect the human lung	6
The development and application of the Environmental Relative Moldiness Index (ERMI)	6
Non-antibiotic compounds associated with humans and the environment can promote horizontal transfer of antimicrobial resistance genes	6
Botanicals as promising antimicrobial agents for enhancing oral health: a comprehensive review	6
Interplay between lipid metabolism, lipid droplets and RNA virus replication	6
Current developments and prospects of the antibiotic delivery systems	5
Probiotics: insights and new opportunities for Clostridioides difficile intervention	5
Transformation of colitis and colorectal cancer: a tale of gut microbiota	5
Ferroptosis, from the virus point of view: opportunities and challenges	5
The role of bacteriophage in inflammatory bowel disease and its therapeutic potential	5
Akkermansia muciniphila plays critical roles in host health	5
Long-Term effects of COVID-19: a review of current perspectives and mechanistic insights	5